Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

690 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis.
Gelsomino F, Casadei-Gardini A, Rossini D, Boccaccino A, Masi G, Cremolini C, Spallanzani A, Viola MG, Garajovà I, Salati M, Elia MT, Caputo F, Santini C, Falcone A, Cascinu S, Tamburini E. Gelsomino F, et al. Among authors: falcone a. Cancers (Basel). 2020 Apr 21;12(4):1022. doi: 10.3390/cancers12041022. Cancers (Basel). 2020. PMID: 32326305 Free PMC article.
Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
Masi G, Cupini S, Marcucci L, Cerri E, Loupakis F, Allegrini G, Brunetti IM, Pfanner E, Viti M, Goletti O, Filipponi F, Falcone A. Masi G, et al. Among authors: falcone a. Ann Surg Oncol. 2006 Jan;13(1):58-65. doi: 10.1245/ASO.2006.03.094. Epub 2006 Jan 1. Ann Surg Oncol. 2006. PMID: 16372158 Clinical Trial.
Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation.
Allegrini G, Di Paolo A, Cerri E, Cupini S, Amatori F, Masi G, Danesi R, Marcucci L, Bocci G, Del Tacca M, Falcone A. Allegrini G, et al. Among authors: falcone a. Cancer Chemother Pharmacol. 2006 Nov;58(5):585-93. doi: 10.1007/s00280-006-0205-x. Epub 2006 May 6. Cancer Chemother Pharmacol. 2006. PMID: 16680463 Clinical Trial.
[Metastatic colorectal cancer: adjournments from ESMO 2006].
Bonetti A, Cascinu S, Falcone A, Maiello E, Zaniboni A, Aschele C. Bonetti A, et al. Among authors: falcone a. Tumori. 2006 Nov-Dec;92(6):1-12. doi: 10.1177/030089160609200627. Tumori. 2006. PMID: 17262903 Italian. No abstract available.
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy.
Scartozzi M, Bearzi I, Pierantoni C, Mandolesi A, Loupakis F, Zaniboni A, Catalano V, Quadri A, Zorzi F, Berardi R, Biscotti T, Labianca R, Falcone A, Cascinu S. Scartozzi M, et al. Among authors: falcone a. J Clin Oncol. 2007 Sep 1;25(25):3930-5. doi: 10.1200/JCO.2007.11.5022. J Clin Oncol. 2007. PMID: 17761976
690 results